The monocarboxylate transporters (MCTs), especially MCT1 and MCT4, are important contributors to induce enhanced glycolysis and tumor aggressiveness (Benjamin et al., 2018; Tasdogan et al., 2020; Zhao et al., 2020). Here, SLC16A3 is linked to neoplasm.